Pfizer Inc. and BioNTech SE announced that the U.S. FDA has approved their supplemental Biologics License Application for the Omicron KP.2-adapted COVID-19 vaccine (COMIRNATY®) for individuals aged 12 and older. The vaccine has also received emergency use authorization for individuals…
EMulate Therapeutics, Inc. has announced that the Open Journal of Biophysics (OJBIPHY) will publish its manuscript, titled “Magnetic Field Emulations of Small Inhibitor RNA: Effects on Implanted GL261 Tumors in C57BL/6 Immune Competent Mice.” This study supports independent findings recently…
Verint® (NASDAQ: VRNT), known as The CX Automation Company™, has announced that a leading healthcare provider is significantly expanding its deployment of the Verint Interaction Wrap Up Bot, increasing its use from 300 to 30,000 agents across its contact center.…
Innovo Therapeutics Inc. has announced promising results from its Phase 2 clinical trial for INV-001, an innovative treatment for post-thyroidectomy scars. The trial, conducted across four hospitals in Korea, including Severance Hospital in Seoul, involved 77 patients with thyroidectomy wounds…
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a leading provider of life science research and clinical diagnostics products, has announced the appointment of Jon DiVincenzo as President and Chief Operating Officer, starting September 9, 2024. DiVincenzo will succeed Andy Last,…
As the youth mental health crisis worsens, Akron Children’s is preparing to introduce a new tool to help teenagers manage anxiety and depression more effectively. Akron Children’s has partnered with Woebot Health to offer Woebot for Adolescents, an AI-powered mental…
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Propofol Injectable Emulsion USP in single-dose vials. The approved dosages include 200 mg/20 mL (10 mg/mL),…
Alcon (SIX/NYSE:ALC), a global leader in eye care, announced its financial results for the second quarter and first half of 2024. In Q2 2024, the company achieved sales of $2.5 billion, marking a 3% increase on a reported basis and…
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a nonprofit healthcare provider serving over one million people in Virginia and West Virginia, have announced a major collaboration. Carilion Clinic will implement Philips’ comprehensive…
Actio Biosciences, a biotechnology firm focused on utilizing a novel genetic and precision medicine platform to create therapeutics for both rare and common diseases, has appointed Dr. Dimitrios Arkilo as Chief Medical Officer (CMO). Dr. Arkilo, a pediatric neurologist with…
Amplitude Vascular Systems (AVS), a medical device company specializing in treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy (IVL) platform, has announced a strategic partnership with the Jacobs Institute, a nonprofit medical device innovation center in Buffalo, N.Y.,…
Weave (NYSE: WEAV), a top all-in-one customer experience and payments platform, has clinched its fourth consecutive Dental Product Shopper Readers’ Choice Award for both Patient Communication and Dental Analytics software. Dental Product Shopper, a leading publication in the dental industry,…